Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2007-12-18
2007-12-18
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S382000, C514S384000, C514S359000, C514S398000, C548S251000, C548S316400, C548S262200, C548S263200, C548S255000, C554S001000, C554S085000, C554S078000
Reexamination Certificate
active
10505257
ABSTRACT:
The present invention encompasses compounds or Formula (I): as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
REFERENCES:
patent: 5677282 (1997-10-01), Oleksyszyn et al.
patent: 5728650 (1998-03-01), Fisher et al.
patent: 5830869 (1998-11-01), Mitchell et al.
patent: 6437165 (2002-08-01), Mandala et al.
patent: 181833 (1986-05-01), None
patent: 467856 (1992-01-01), None
patent: 778263 (1997-11-01), None
patent: WO 98/40055 (1988-09-01), None
patent: WO96/31124 (1996-04-01), None
patent: WO 97/25315 (1997-07-01), None
patent: WO02/18395 (2002-03-01), None
Lopez, et al., Tetrahedron, “N-(Diphenylmethylene) glycinate as Anionic Glycine Equivalent. Monoalkylation, Dialkylation and Michael Additions Under Solid-Liquid Phase-Transfer Catalysis”, vol. 52, No. 24, pp. 8365-8386, 1996.
Guillena, et al., Tetrahedron, “Stereoselective Synthesis of 2,3-Disubstituted Glutamic Acid Derivatives by Conjugate Addition to 3,4-Didehydropyroglutamates”, vol. 54, No. 32, pp. 9447-9456, 1998.
Borea, et al., Farmaco, Ed. Sci., Brain Receptor Binding of Analogues of Υ-Aminobutyric Acid (GABA), vol. 38, No. 6, pp. 411-417, 1983.
Yanagisawa, et al., Chemistry Letters, “Synthesis of Statine and Its Analogues”, vol. 4, pp. 687-690, 1989.
Guillena, et al., “Synthesis of 2-substituted 4-methyleneglutamic acids and their cyclopropyl analogues”, Anales de Quimica Int. ed., vol. 92, pp. 362-369, 1996.
Chemical Abstract, Database Accession No. RN 330645-19-7.
Chemical Abstract, Database Accession No. RN 339345-94-7.
Child, R.G., et al—ARZNEIM—Forsch, vol. 30, No. 1, pp. 695-702, 1980.
Chemical Abstract, Database Accession No. RN333429-89-3.
Chemical Abstract, Database Accession No. RN3833373-17-9.
Chemical Abstract, Database Accession No. RN372144-19-9.
Budhu Richard J.
Doherty George A.
Hale Jeffrey J.
Lynch Christopher L.
Mills Sander G.
Anderson Rebecca
Chu Yong
Krovatin William
Merck & Co. , Inc.
Yuro Raynard
LandOfFree
Aminoalkylphosphonates and related compounds as Edg receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoalkylphosphonates and related compounds as Edg receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoalkylphosphonates and related compounds as Edg receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3876410